文献速递急性肾损伤慢性肾脏病

严重急性肾损伤后调节微生物组可加速功能恢复并减少肾脏纤维化

Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosis.
PubMed 文献 · Kidney Int · 2023-04-01

该研究在小鼠严重缺血性急性肾损伤后使用抗生素(尤其是阿莫西林)调节肠道微生物组,发现可加速肾小球滤过率恢复、减轻肾脏纤维化并降低促纤维化基因表达。阿莫西林的效果依赖于微生物组和CD8+T淋巴细胞,在无菌或CD8缺陷小鼠中无效,但在CD4缺陷小鼠中仍有效。阿莫西林预处理对双侧缺血再灌注损伤有保护作用,但对顺铂诱导的急性肾损伤无保护作用。

要点

  • 小鼠严重缺血性急性肾损伤后使用阿莫西林可加速肾功能恢复并减少肾脏纤维化。
  • 阿莫西林改变肠道菌群(增加Alistipes、Odoribacter、Stomatobaculum,耗竭Holdemanella和Anaeroplasma)。
  • 阿莫西林保护作用依赖微生物组和CD8+T淋巴细胞,在无菌或CD8缺陷小鼠中无效。

核心结论

  • 严重缺血性急性肾损伤后使用阿莫西林调节肠道细菌是加速肾功能恢复和减轻急性肾损伤向慢性肾脏病进展的有前景的新治疗策略。

研究设计与样本

  • 在小鼠严重缺血性肾脏损伤后使用抗生素(特别是阿莫西林)调节肠道微生物组,并纳入无菌小鼠、CD8缺陷小鼠和CD4缺陷小鼠进行机制验证。

主要发现

  • 阿莫西林加速恢复的指标包括增加肾小球滤过率、减轻肾脏纤维化和减少肾脏促纤维化基因表达。
  • 阿莫西林增加粪便Alistipes、Odoribacter和Stomatobaculum菌种,同时显著耗竭Holdemanella和Anaeroplasma。
  • 阿莫西林减少肾脏CD4+T细胞、白细胞介素(IL)-17+CD4+T细胞和肿瘤坏死因子-α双阴性T细胞,同时增加CD8+T细胞和PD1+CD8+T细胞。
  • 阿莫西林增加肠道固有层CD4+T细胞,同时减少CD8+T细胞和IL-17+CD4+T细胞。
  • 阿莫西林在无菌或CD8缺陷小鼠中不加速修复;在CD4缺陷小鼠中仍有效;来自阿莫西林处理小鼠的粪菌移植给无菌小鼠可减少肾脏纤维化并增加Foxp3+CD8+T细胞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Targeting gut microbiota has shown promise to prevent experimental acute kidney injury (AKI). However, this has not been studied in relation to accelerating recovery and preventing fibrosis. Here, we found that modifying gut microbiota with an antibiotic administered after severe ischemic kidney injury in mice, particularly with amoxicillin, accelerated recovery. These indices of recovery included increased glomerular filtration rate, diminution of kidney fibrosis, and reduction of kidney profibrotic gene expression. Amoxicillin was found to increase stool Alistipes, Odoribacter and Stomatobaculum species while significantly depleting Holdemanella and Anaeroplasma. Specifically, amoxicillin treatment reduced kidney CD4+T cells, interleukin (IL)-17 +CD4+T cells, and tumor necrosis factor-α double negative T cells while it increased CD8+T cells and PD1+CD8+T cells. Amoxicillin also increased gut lamina propria CD4+T cells while decreasing CD8+T and IL-17+CD4+T cells. Amoxicillin did not accelerate repair in germ-free or CD8-deficient mice, demonstrating microbiome and CD8+T lymphocytes dependence for amoxicillin protective effects. However, amoxicillin remained effective in CD4-deficient mice. Fecal microbiota transplantation from amoxicillin-treated to germ-free mice reduced kidney fibrosis and increased Foxp3+CD8+T cells. Amoxicillin pre-treatment protected mice against kidney bilateral ischemia reperfusion injury but not cisplatin-induced AKI. Thus, modification of gut bacteria with amoxicillin after severe ischemic AKI is a promising novel therapeutic approach to accelerate recovery of kidney function and mitigate the progression of AKI to chronic kidney disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Gharaie S, Lee K, Newman-Rivera AM, et al. Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosis. Kidney Int. 2023. PMID: 37011727. doi:10.1016/j.kint.2023.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。